Shenzhen Lifotronic Technology Co.Ltd(688389) : ecl9000 series products of chemiluminescence immunoanalyzer have obtained the medical device registration certificate

On the evening of February 15, Shenzhen Lifotronic Technology Co.Ltd(688389) announced that Chongqing pumenchuang Biotechnology Co., Ltd., the holding subsidiary of the company, had recently received the medical device registration certificate of the people’s Republic of China issued by Chongqing drug administration. The reporter learned from the company that the medical device registration certificate obtained this time is a large and high-speed electrochemiluminescence detection equipment of the company – full-automatic chemiluminescence immunoanalyzer ecl9000 series products.

According to the company, ecl9000 series products adopt tripyridine ruthenium direct Electrochemiluminescence Method, and the detection speed of a single module can reach 300 tests / hour. Through the cascade expansion function of four-level detection modules, the detection speed can reach 1200 tests / hour. In the next step, the product plans to cascade with 2000 tests / hour high-speed biochemical analyzer to form a large biochemical immune cascade pipeline; The disposable tip head is used to suck samples, which improves the detection accuracy and ensures the accuracy of the results; The results of emergency items (such as inflammation and cardiovascular markers) can be produced within 10 minutes to meet the requirements of clinical emergency.

The company said that ecl9000 series products are used for accurate and quantitative detection of analytes in human serum and plasma samples, and the supporting testing items cover 80 items in 13 categories, including inflammation, cardiovascular markers, tumor markers and hormones; It is applicable to customers with large sample size, including tens of thousands of professional users such as clinical laboratories of various medium and large hospitals, physical examination centers, independent laboratories, third-party chain testing institutions and higher medical research institutes. It will comprehensively improve the industry competitiveness of the company’s electrochemiluminescence products and lay a solid foundation for the growth of international and Chinese sales revenue.

- Advertisment -